Health

How cardamom could help tackle breast cancer

Its effectiveness is attributed to cardamonin, a natural component present in the spice

Updated 4 years ago · Published on 14 Apr 2022 2:00PM

How cardamom could help tackle breast cancer
According to an American study, cardamom, a plant of Indian origin, could help fight against triple-negative breast cancer. – ETX Daily Up pic, April 14, 2022

ACCORDING to an American study, cardamom, a plant of Indian origin, could fight against triple-negative breast cancer cells. This discovery could enable scientists to look for new ways to fight this kind of cancer, which may develop resistance to the usual treatments.

Cardamom has many natural virtues, including therapeutic properties.

According to researchers at the Florida Agricultural and Mechanical University, this plant could help fight against triple-negative breast cancer cells. Its effectiveness is attributed to cardamonin, a natural component present in the spice.

Triple-negative breast cancers are a significant health issue because they are difficult to treat. They develop with no known markers on the surface of the cancer cells that would respond to a known targeted therapy, explains the Institut Curie research centre. 

To conduct their research, Dr Patricia Mendonca and colleagues studied the effects of cardamonin on two triple-negative breast cancer cell lines – one composed of cells from African American women and the other of cells from Caucasian women.

The researchers observed how cardamonin affected the expression of the Ligand-1 (PD-L1) gene, which is responsible for programmed cell death. In patients with triple-negative breast cancer, PD-L1 is over-expressed, "and plays a critical role in helping breast cancer cells evade the body's immune system," the study explains.

The researchers found that cardamonin treatment could decrease the viability of cancer cells in both African-American and Caucasian patients. In addition, it reduced PD-L1 expression in the Caucasian cell line but not the African American cell line.

"This is the first study to describe cardamonin's inhibitory effect on the expression of PD-L1, which is relevant for the treatment of triple-negative breast cancer," said Mendonca. "These findings add support to other research that has shown differences in the tumour microenvironment between African and non-African Americans."

More research is needed before the treatment can be tested on humans. – ETX Daily Up, April 14, 2022

Related News

Health / 3y

Breast cancer drug shown to reduce recurrence risk

Malaysia / 3y

Breast cancer support group seeks to purchase own halfway home

Malaysia / 3y

Breast cancer the leading cause of cancer deaths among women: Nancy

Health / 3y

Debunking 10 common nutrition and diet-related breast cancer myths

Health / 3y

One mil children lose mothers to cancer a year: research

Women / 3y

A sisterhood of support while battling breast cancer

Spotlight

Malaysia

Anwar congratulates BN on Johor victory, assures federal government support

Malaysia

Johor PRN: BN officially forms state government, wins 29 seats

Malaysia

Malaysia-Thailand open historic border crossing to deepen trade, regional integration

By Ian McIntyre

Malaysia

Gerak Khas drama actress, Tisha Samsir denies drug involvement

Malaysia

Student stabbing: Teenage girl sent to Hospital Bahagia for psychiatric evaluation

Malaysia

Anwar wishes Tun M a happy 101st birthday

World

Israel shares intelligence with US over alleged Iranian plot to assassinate Trump

You may be interested

Events

HashMicro rolls out AI-powered manufacturing platform to help firms tackle rising costs, disruptions

By Alfian Z.M. Tahir